A major UK clinical trial has shown that adding the corticosteroid dexamethasone to standard antiviral treatment for encephalitis (brain inflammation), caused by herpes simplex virus (HSV) does not ...

A major UK clinical trial has shown that adding the corticosteroid dexamethasone to standard antiviral treatment for ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

Researchers use cryo-EM and optical tweezers to investigate how an antiviral interacts with the herpes simplex virus.

Herpes simplex virus (HSV) research continues to be a dynamic and interdisciplinary field encompassing virology, immunology, gene therapy and structural biology. Central to these studies is the ...

The incidence of neonatal herpes simplex virus (HSV) infections in the UK and Ireland increased dramatically over 15 years, and outcomes remained poor, with mortality and long-term neurologic ...

Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical company, and Innovative Molecules GmbH ("Innovative Molecules"), a clinical-stage biotechnology company, today announced a strategic partnership ...

Herpes has been called “the gift that keeps on giving” — finally, its presence has come in handy. Roughly two-thirds of the global population has been infected with herpes simplex virus type 1 (HSV-1) ...

This is read by an automated voice. Please report any issues or inconsistencies here. Cancer-fighting, genetically engineered herpes simplex virus has been shown to be an effective treatment for ...

Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells. A single dose of the modified virus increased T-cell, ...